Deyang Huatai Biopharm Resource Co.,Ltd. Company Profile

06:58 EDT 19th March 2018 | BioPortfolio

HUATAI aims to be the most reliable, cost-effective and professional global supplier of natural products for human health.Supported by its manufacturing and logistic expertise, Huatai also dedicates to combine China's source with world-wide distributors/end-users to create a global seamless chain providing efficent, high quality and value-added services to its customers both on a local and global level.


3rd, Floor, Dang'an Building Southern Lushan Road
Deyang City


Phone: 86 838 2508935, 2508868
Fax: 86 838 2515973

News Articles [165 Associated News Articles listed on BioPortfolio]

Scotland's TC BioPharm joins bluebird to develop next-gen CAR-T

US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR-T cells. As reported by pharmaphorum earlier this year, TC BioPharm has already won EU funding...

#jobs #lifescience Sales – Manager/Biopharm/Immunology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sales – Manager/Biopharm/Immunology .MD-Rockville, Sales Manager/Biopha...

bluebird bio and TC BioPharm to develop new cancer immunotherapies

US-based gene therapies company bluebird bio has entered a strategic collaboration and licence agreement with Scottish immunotherapy firm TC BioPharm...Read More... The post bluebird bio and TC BioPha...

bluebird bio and TC BioPharm Collaborate to Develop Gamma Delta CAR T Cell Products for Cancer Immunotherapy

CAMBRIDGE, Mass. & EDINBURGH, Scotland–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) and Scottish immunotherapy company TC BioPharm, Ltd. (TCB) today announced a strategic collabo...

TC BioPharm and bluebird bio team up for gamma delta CART therapies

TC BioPharm Ltd. and bluebird bio Inc. penned a deal for the discovery and development of CAR-engineered gamma T-cell therapies for cancer.

bluebird bio, TC BioPharm to develop Gamma Delta CAR T cell product candidates for cancer immunotherapy

bluebird bio and Scottish immunotherapy company TC BioPharm have partnered and signed a license agreement on gamma delta CAR T cells.

Dance Biopharm to develop inhaled insulin with Phillips-Medisize

US biotech Dance Biopharm is to work with Phillips-Medisize, to develop a version of its inhaled insulin device that has data connectivity for better management of diabetes treatment. Inhaled insulin...

bluebird, TC BioPharm in gamma delta CAR T deal

PubMed Articles [417 Associated PubMed Articles listed on BioPortfolio]

A cross-national study of the association between natural resource rents and homicide rates, 2000-12.

Countries that rely on natural resource rents (that is, the revenue generated from the sale of natural resources) may suffer from a variety of social problems. This exploratory study reviews the natur...

Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" Eur. J. Pharm. Biopharm. 119 (2017) 253-263.

Headache in Resource-Limited Settings.

This review summarizes the unmet need of headache burden and management in resource-limited settings. It provides a general overview of the nuances and peculiarities of headache disorders in resource-...

Optimized maritime emergency resource allocation under dynamic demand.

Emergency resource is important for people evacuation and property rescue when accident occurs. The relief efforts could be promoted by a reasonable emergency resource allocation schedule in advance. ...

Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology.

Ventilator-associated respiratory infection (VARI) is a significant problem in resource-restricted intensive care units (ICUs), but differences in casemix and etiology means VARI in resource-restricte...

Clinical Trials [442 Associated Clinical Trials listed on BioPortfolio]

ORaClES: A Trial to Improve Prognostication

This study evaluates whether an online training resource can improve the performance of medical students in recognising imminently dying palliative care patients.

Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)

The purpose of this study is to determine if providing a county specific electronic resource guide with low and no cost services to outpatient substance abuse counselors, results in more a...

Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery

This study investigates the association of preoperative anticholinergic medication exposure with healthcare resource utilization in a population-based sample of older patients enrolled in ...

Singing for People With Aphasia

To undertake a pilot study that will evaluate the feasibility and acceptability of procedures to inform the design and delivery of a definitive RCT of SPA (which would assess the clinical ...

HIV Viral Load Monitoring in Resource-Poor Settings

No randomized clinical trial to date has demonstrated a survival benefit of using regular HIV-1 ribonucleic acid (RNA) viral load (VL) testing to monitor patients' responses to antiretrovi...

Companies [560 Associated Companies listed on BioPortfolio]

Deyang Huatai Biopharm Resource Co.,Ltd.

HUATAI aims to be the most reliable, cost-effective and professional global supplier of natural products for human health.Supported by its manufacturing and logistic expertise, Huatai also dedicates t...

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.


Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

More Information about "Deyang Huatai Biopharm Resource Co.,Ltd." on BioPortfolio

We have published hundreds of Deyang Huatai Biopharm Resource Co.,Ltd. news stories on BioPortfolio along with dozens of Deyang Huatai Biopharm Resource Co.,Ltd. Clinical Trials and PubMed Articles about Deyang Huatai Biopharm Resource Co.,Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Deyang Huatai Biopharm Resource Co.,Ltd. Companies in our database. You can also find out about relevant Deyang Huatai Biopharm Resource Co.,Ltd. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record